Jane Street’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Jane Street’s Portfolio FTXH Stock Details FTXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,010	Closed	-$397K	–	9937
2022 Q2	$397K	Buy	+15,010	New	+$397K	﹤0.01%	7142
2020 Q1	–	Sell	-22,283	Closed	-$519K	–	5531
2019 Q4	$519K	Sell	22,283 -6,773	-23%	-$147K	﹤0.01%	3642
2019 Q3	$592K	Sell	29,056 -1,927	-6%	-$39.7K	﹤0.01%	3328
2019 Q2	$655K	Buy	30,983 +16,915	+120%	+$351K	﹤0.01%	3241
2019 Q1	$301K	Sell	14,068 -23,277	-62%	-$484K	﹤0.01%	4244
2018 Q4	$717K	Buy	+37,345	New	+$803K	﹤0.01%	3011
2018 Q3	–	Sell	-45,294	Closed	-$983K	–	5299
2018 Q2	$983K	Buy	+45,294	New	+$963K	﹤0.01%	2765
2018 Q1	–	Sell	-23,910	Closed	-$512K	–	4983
2017 Q4	$512K	Buy	+23,910	New	+$492K	﹤0.01%	3142

Other funds holding FTXH

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

WFA

WMG Financial Advisors Knoxville, Tennessee $265M AUM 26.01% 1-Year Est. Return

Integrated Advisors Network Dallas, Texas $2.19B AUM 21.82% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Kesler Norman & Wride Ogden, Utah $631M AUM 27.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street's FTXH Position: Q3 2022 in Review

Jane Street sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2022, closing a stake of 15,010 shares — an estimated $397K sold.

Jane Street first reported a position in FTXH in Q4 2017 and held it in 8 quarters. The position peaked at $983K in Q2 2018. 26 funds tracked by Wall St. Rank hold FTXH as of Q3 2022.

Jane Street reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
Jane Street sold 15,010 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2022, an estimated $397K.
Jane Street first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q4 2017 and held it in 8 quarters.
Jane Street's First Trust Nasdaq Pharmaceuticals ETF position peaked at $983K in Q2 2018.
26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.